Concepedia

Lihua E. Budde

LE

Statistics

Publications

92

Citations

7K

H-Index

36

Active since

2010

Affiliations

City Of Hope National Medical Center(Current)

City of Hope

The University of Texas MD Anderson Cancer Center

Fred Hutch Cancer Center

Washington University in St. Louis

Lihua E. Budde is an author at City Of Hope National Medical Center specializing in immunotherapy, immunology, and medicine.

ORCID

Top concepts

Publications per year

2010–2024

92

Publications

92

Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma

Frederick L. Locke, Sattva S. Neelapu, Nancy L. Bartlett et al. · Molecular Therapy · 2017 · 601 citations · Full text

Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology

John A. Thompson, Bryan J. Schneider, Julie R. Brahmer et al. · Journal of the National Comprehensive Cancer Network · 2019 · 549 citations · Full text

CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results

Brian G. Till, Michael C. Jensen, Jinjuan Wang et al. · Blood · 2012 · 528 citations · Full text

NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020

John A. Thompson, Bryan J. Schneider, Julie R. Brahmer et al. · Journal of the National Comprehensive Cancer Network · 2020 · 470 citations · Full text

Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study

Lihua E. Budde, Laurie H. Sehn, Matthew J. Matasar et al. · The Lancet Oncology · 2022 · 390 citations

, , +7

1–5 of 92